PACS1 Research Hub

This Research section presents an independent, open-science investigation into pharmacological therapies for PACS1 syndrome (Schuurs-Hoeijmakers, OMIM #615009), focused on the recurrent p.Arg203Trp mutation found in ~98% of affected patients.